Medical Science Liaison, Oncology, South Korea & Taiwan at IQVIA

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

NoVisa

Pharmaceuticals, Oncology, Clinical ResearchIndustries

Requirements

MD, PhD, PharmD preferred; master’s degree with relevant expertise considered
At least 2 years’ experience as an MSL or in a related scientific/medical role
Proven oncology background, especially with solid tumors
In-depth knowledge of clinical trial execution and site activation strategies
Fluent in Korean and English for South Korea; Mandarin and English for Taiwan. Japanese fluency is a plus
Authorization to work in South Korea and/or Taiwan plus willingness for significant travel
Valid driver’s license

Responsibilities

Deliver site-focused medical and scientific support for oncology studies in South Korea and Taiwan
Host scientific discussions, protocol training, and therapeutic updates for site staff and investigators
Identify and troubleshoot barriers to patient enrollment and protocol compliance
Work closely with site management and IQVIA project teams to drive effective site performance
Foster compliant scientific dialogue with HCPs and KOLs in both countries
Collect and relay actionable field intelligence to central teams
Attend and represent the program at local and international oncology conferences and advisory panels
Keep expertise current on regional oncology trends, disease states, and investigational assets
Adhere to all local laws, regulations, and company procedures in daily activities

Skills

Key technologies and capabilities for this role

OncologyMedical Science LiaisonClinical TrialsKOL EngagementHCP InteractionsProtocol ComplianceSite ManagementPatient EnrollmentScientific CommunicationKoreanMandarinEnglish

Questions & Answers

Common questions about this position

What qualifications are required for the Medical Science Liaison role?

Candidates need an MD, PhD, or PharmD preferred, or a master’s degree with relevant expertise, at least 2 years’ experience as an MSL or in a related role, proven oncology background especially with solid tumors, in-depth knowledge of clinical trial execution, fluency in Korean and English for South Korea or Mandarin and English for Taiwan, authorization to work in South Korea and/or Taiwan, willingness for significant travel, and a valid driver’s license.

Is this a remote position or does it require travel?

This is a field-based role requiring significant travel, with work focused on oncology trial sites in South Korea and Taiwan.

What is the salary or compensation for this position?

This information is not specified in the job description.

What kind of team will I be working with in this role?

You'll work closely with site management, IQVIA project teams, HCPs, KOLs, and a global MSL team operating in 26 countries worldwide.

What makes a strong candidate for this MSL position?

A strong candidate has an advanced degree like MD/PhD/PharmD, 2+ years MSL experience, oncology expertise in solid tumors, clinical trial knowledge, regional language fluency, and readiness for field-based travel.

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free